In December 2005, 40-year-old John Danner was going to make his first presentation towards the board of company directors of Codon Devices, a 1-year-old biotechnology start-up located in Cambridge, Massachusetts. Following a month because the company's CEO, Danner was ready to construct his proper arrange for the firm. The organization was quickly taking be part of the big DNA-synthesis market. Codon had several distinctive features for an organization its size and age: it had been already producing revenue from the 3 various kinds of customer because of its genetic items it looked able to changing the landscape of the fragmented DNA-synthesis sell it off received remarkable support from the extra-large Scientific Advisory Board it acquired and guaranteed a powerful ip portfolio that produces high obstacles to entry for just about any new market newcomers and, it had $13 million of investment capital investment from Flagship Endeavors, Khosla Endeavors, Kleiner-Perkins, yet others.
Estimated Submission On |